Rohto Advanced Research Hong Kong Limitedarhkwas Established In January 2019 By A Japanese Company Called Rohto Pharmaceutical Co Ltdrohto The Core Businesses Of Rohto Are Pharmaceutical Products Including Eye Dropscosmetics And Functional Foodsin Research Fieldrohto Specializes In Developing Cell Culture Techniques And As Well As Utilizing An Aseptic Automated System For Manufacturing Their Products Such As Eye Drops And Cosmetics One Of The Main Research Areas Rohto Focuses On Is Regenerative Medicinein 2017Rohto Started Its First Clinical Trial Using Allogenic Adipose Derived Mesenchymal Stromal Cells Against Liver Cirrhosisin 2020A Clinical Trial Against Severe Covid 19 Pneumonia Was Also Initiatedentering Phase Ii Trials In 2021Several More Clinical Trials Are Ongoing Against Various Target Indications In Japanin Accordance With The Strategic Planning And Development Of Regenerative Medicine And Its Related Businessesarhk Utilizes Rohto S Expertise And Cutting Edge Technologies To Contribute To The Advancement Of Scientific Research And People S Wellness Arhk Is Currently Conducting Scientific Research On Mesenchymal Stromal Cells In Collaboration With Multiple Parties In Hong Kongand Worldwide
